The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection
Open accessAbstract
Toll-like receptors (TLRs) are sensors that recognize molecular patterns from viruses, bacteria, and fungi to initiate innate immune responses to invading pathogens. The emergence of highly pathogenic coronaviruses severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) is a concern for global public health, as there is a lack of efficacious vaccine platforms and antiviral therapeutic strategies. Previously, it was shown that MyD88, an adaptor protein necessary for signaling by multiple TLRs, is a required component of the innate immune response to mouse-adapted SARS-CoV infection in vivo . Here, we demonstrate that TLR3 −/− , TLR4 −/− , and TRAM −/− mice are more susceptible to SARS-CoV than wild-type mice but experience only transient weight loss with no mortality in response to infection. In contrast, mice deficient in the TLR3/TLR4 adaptor TRIF are highly susceptible to SARS-CoV infection, showing increased weight loss, mortality, reduced lung function, increased lung pathology, and higher viral titers. Distinct alterations in inflammation were present in TRIF −/− mice infected with SARS-CoV, including excess infiltration of neutrophils and inflammatory cell types that correlate with increased pathology of other known causes of acute respiratory distress syndrome (ARDS), including influenza virus infections. Aberrant proinflammatory cytokine, chemokine, and interferon-stimulated gene (ISG) signaling programs were also noted following infection of TRIF −/− mice that were similar to those seen in human patients with poor disease outcome following SARS-CoV or MERS-CoV infection. These findings highlight the importance of TLR adaptor signaling in generating a balanced protective innate immune response to highly pathogenic coronavirus infections. IMPORTANCE Toll-like receptors are a family of sensor proteins that enable the immune system to differentiate between “self” and “non-self.” Agonists and antagonists of TLRs have been proposed to have utility as vaccine adjuvants or antiviral compounds. In the last 15 years, the emergence of highly pathogenic coronaviruses SARS-CoV and MERS-CoV has caused significant disease accompanied by high mortality rates in human populations, but no approved therapeutic treatments or vaccines currently exist. Here, we demonstrate that TLR signaling through the TRIF adaptor protein protects mice from lethal SARS-CoV disease. Our findings indicate that a balanced immune response operating through both TRIF-driven and MyD88-driven pathways likely provides the most effective host cell intrinsic antiviral defense responses to severe SARS-CoV disease, while removal of either branch of TLR signaling causes lethal SARS-CoV disease in our mouse model. These data should inform the design and use of TLR agonists and antagonists in coronavirus-specific vaccine and antiviral strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,735
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574
Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway
Yamamoto, M., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Sanjo, H., Takeuchi, O., Sugiyama, M., Okabe, M., Takeda, K., et al. (2003) · Science · doi:10.1126/science.1087262 · Cited by 3,235
Monocyte recruitment during infection and inflammation
Shi, C., & Pamer, E. G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3070 · Cited by 3,015
The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling
O'Neill, L. A. J., & Bowie, A. G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2079 · Cited by 2,667
Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor
Ge, X.-Y., Li, J.-L., Yang, X.-L., Chmura, A. A., Zhu, G., Epstein, J. H., Mazet, J. K., Hu, B., Zhang, W., Peng, C., et al. (2013) · Nature · doi:10.1038/nature12711 · Cited by 1,778
Imai, Y., Kuba, K., Neely, G. G., Yaghubian-Malhami, R., Perkmann, T., van Loo, G., Ermolaeva, M., Veldhuizen, R., Leung, Y. H. C., Wang, H., et al. (2008) · Cell · doi:10.1016/j.cell.2008.02.043 · Cited by 1,356
Noninvasive Measurement of Airway Responsiveness in Allergic Mice Using Barometric Plethysmography
HAMELMANN, E., SCHWARZE, J., TAKEDA, K., OSHIBA, A., LARSEN, G. L., IRVIN, C. G., & GELFAND, E. W. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.3.9606031 · Cited by 1,286
Yamamoto, M., Sato, S., Mori, K., Hoshino, K., Takeuchi, O., Takeda, K., & Akira, S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.12.6668 · Cited by 1,227
SARS: systematic review of treatment effects
Stockman, L. J., Bellamy, R., & Garner, P. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030343 · Cited by 1,217 · cited 1×
“Despite the importance of SARS-CoV and MERS-CoV as public health threats, there are currently no available antivirals against these pathogens, with current evidence suggesting that the antiviral drugs ribavirin and interferon (IFN) are not efficacious in ameliorating SARS or MERS infections (7) (8) (9) .”
BackgroundOshiumi, H., Matsumoto, M., Funami, K., Akazawa, T., & Seya, T. (2003) · Nature Immunology · doi:10.1038/ni886 · Cited by 1,207
Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis
Wang, T., Town, T., Alexopoulou, L., Anderson, J. F., Fikrig, E., & Flavell, R. A. (2004) · Nature Medicine · doi:10.1038/nm1140 · Cited by 1,155
Züst, R., Cervantes-Barragan, L., Habjan, M., Maier, R., Neuman, B. W., Ziebuhr, J., Szretter, K. J., Baker, S. C., Barchet, W., Diamond, M. S., et al. (2011) · Nature Immunology · doi:10.1038/ni.1979 · Cited by 811
Stevenson, G. W., Hoang, H., Schwartz, K. J., Burrough, E. R., Sun, D., Madson, D., Cooper, V. L., Pillatzki, A., Gauger, P., Schmitt, B. J., et al. (2013) · Journal of Veterinary Diagnostic Investigation · doi:10.1177/1040638713501675 · Cited by 704
Guillot, L., Le Goffic, R., Bloch, S., Escriou, N., Akira, S., Chignard, M., & Si-Tahar, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410592200 · Cited by 689
Perrone, L. A., Plowden, J. K., García-Sastre, A., Katz, J. M., & Tumpey, T. M. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000115 · Cited by 623
Pathogenesis of influenza-induced acute respiratory distress syndrome
Short, K. R., Kroeze, E. J. B. V., Fouchier, R. A. M., & Kuiken, T. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70286-x · Cited by 538
Goffic, R. L., Balloy, V., Lagranderie, M., Alexopoulou, L., Escriou, N., Flavell, R., Chignard, M., & Si-Tahar, M. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020053 · Cited by 514
Bolles, M., Deming, D., Long, K., Agnihothram, S., Whitmore, A., Ferris, M., Funkhouser, W., Gralinski, L., Totura, A., Heise, M., et al. (2011) · Journal of Virology · doi:10.1128/jvi.06048-11 · Cited by 477
Self-citationRapid generation of a mouse model for Middle East respiratory syndrome
Zhao, J., Li, K., Wohlford-Lenane, C., Agnihothram, S. S., Fett, C., Zhao, J., Gale, M. J., Baric, R. S., Enjuanes, L., Gallagher, T., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323279111 · Cited by 452
Self-citationA Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice
Roberts, A., Deming, D., Paddock, C. D., Cheng, A., Yount, B., Vogel, L., Herman, B. D., Sheahan, T., Heise, M., Genrich, G. L., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030005 · Cited by 447
Self-citationThe TLR4 antagonist Eritoran protects mice from lethal influenza infection
Shirey, K. A., Lai, W., Scott, A. J., Lipsky, M., Mistry, P., Pletneva, L. M., Karp, C. L., McAlees, J., Gioannini, T. L., Weiss, J., et al. (2013) · Nature · doi:10.1038/nature12118 · Cited by 423
A Strategy To Estimate Unknown Viral Diversity in Mammals
Anthony, S. J., Epstein, J. H., Murray, K. A., Navarrete-Macias, I., Zambrana-Torrelio, C. M., Solovyov, A., Ojeda-Flores, R., Arrigo, N. C., Islam, A., Ali Khan, S., et al. (2013) · mBio · doi:10.1128/mbio.00598-13 · Cited by 415
The mercurial nature of neutrophils: still an enigma in ARDS?
Williams, A. E., & Chambers, R. C. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00311.2013 · Cited by 415
Cameron, M. J., Ran, L., Xu, L., Danesh, A., Bermejo-Martin, J. F., Cameron, C. M., Muller, M. P., Gold, W. L., Richardson, S. E., Poutanen, S. M., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00527-07 · Cited by 386
Zhang, Z., Kim, T., Bao, M., Facchinetti, V., Jung, S. Y., Ghaffari, A. A., Qin, J., Cheng, G., & Liu, Y.-J. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.027 · Cited by 375
Guillot, L., Medjane, S., Le-Barillec, K., Balloy, V., Danel, C., Chignard, M., & Si-Tahar, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m305790200 · Cited by 359
Toll-Like Receptor 3 Has a Protective Role against West Nile Virus Infection
Daffis, S., Samuel, M. A., Suthar, M. S., Gale, M., & Diamond, M. S. (2008) · Journal of Virology · doi:10.1128/jvi.00935-08 · Cited by 358
Schwarze, J., Hamelmann, E., Bradley, K. L., Takeda, K., & Gelfand, E. W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119516 · Cited by 328
Al-Tawfiq, J. A., Momattin, H., Dib, J., & Memish, Z. A. (2014) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2013.12.003 · Cited by 322
Mechanisms of Severe Acute Respiratory Syndrome Coronavirus-Induced Acute Lung Injury
Gralinski, L. E., Bankhead, A., Jeng, S., Menachery, V. D., Proll, S., Belisle, S. E., Matzke, M., Webb-Robertson, B.-J. M., Luna, M. L., Shukla, A. K., et al. (2013) · mBio · doi:10.1128/mbio.00271-13 · Cited by 310
Self-citationMenachery, V. D., Eisfeld, A. J., Schäfer, A., Josset, L., Sims, A. C., Proll, S., Fan, S., Li, C., Neumann, G., Tilton, S. C., et al. (2014) · mBio · doi:10.1128/mbio.01174-14 · Cited by 305
Self-citationIchikawa, A., Kuba, K., Morita, M., Chida, S., Tezuka, H., Hara, H., Sasaki, T., Ohteki, T., Ranieri, V. M., dos Santos, C. C., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201203-0508oc · Cited by 289
Respiratory Syncytial Virus Up-regulates TLR4 and Sensitizes Airway Epithelial Cells to Endotoxin
Monick, M. M., Yarovinsky, T. O., Powers, L. S., Butler, N. S., Carter, A. B., Gudmundsson, G., & Hunninghake, G. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308093200 · Cited by 276
Deming, D., Sheahan, T., Heise, M., Yount, B., Davis, N., Sims, A., Suthar, M., Harkema, J., Whitmore, A., Pickles, R., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030525 · Cited by 275
Self-citationInhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin
Falzarano, D., de Wit, E., Martellaro, C., Callison, J., Munster, V. J., & Feldmann, H. (2013) · Scientific Reports · doi:10.1038/srep01686 · Cited by 273
Distinct Immune Response in Two MERS-CoV-Infected Patients: Can We Go from Bench to Bedside?
Faure, E., Poissy, J., Goffard, A., Fournier, C., Kipnis, E., Titecat, M., Bortolotti, P., Martinez, L., Dubucquoi, S., Dessein, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088716 · Cited by 248
Menachery, V. D., Yount, B. L., Josset, L., Gralinski, L. E., Scobey, T., Agnihothram, S., Katze, M. G., & Baric, R. S. (2014) · Journal of Virology · doi:10.1128/jvi.03571-13 · Cited by 212
Self-citationSeo, S.-U., Kwon, H.-J., Ko, H.-J., Byun, Y.-H., Seong, B. L., Uematsu, S., Akira, S., & Kweon, M.-N. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001304 · Cited by 211
MyD88 Is Required for Protection from Lethal Infection with a Mouse-Adapted SARS-CoV
Sheahan, T., Morrison, T. E., Funkhouser, W., Uematsu, S., Akira, S., Baric, R. S., & Heise, M. T. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000240 · Cited by 207
Self-citationRudd, B. D., Smit, J. J., Flavell, R. A., Alexopoulou, L., Schaller, M. A., Gruber, A., Berlin, A. A., & Lukacs, N. W. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1937 · Cited by 189
Kumar, H., Koyama, S., Ishii, K. J., Kawai, T., & Akira, S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.2.683 · Cited by 162
Viral infection of the lung: Host response and sequelae
Yoo, J.-K., Kim, T. S., Hufford, M. M., & Braciale, T. J. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.06.006 · Cited by 161
Frieman, M. B., Chen, J., Morrison, T. E., Whitmore, A., Funkhouser, W., Ward, J. M., Lamirande, E. W., Roberts, A., Heise, M., Subbarao, K., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000849 · Cited by 158
Self-citationIntranasal Treatment with Poly(I·C) Protects Aged Mice from Lethal Respiratory Virus Infections
Zhao, J., Wohlford-Lenane, C., Zhao, J., Fleming, E., Lane, T. E., McCray, P. B., & Perlman, S. M. (2012) · Journal of Virology · doi:10.1128/jvi.01410-12 · Cited by 145
Iwata‐Yoshikawa, N., Uda, A., Suzuki, T., Tsunetsugu‐Yokota, Y., Sato, Y., Morikawa, S., Tashiro, M., Sata, T., Hasegawa, H., & Nagata, N. (2014) · Journal of Virology · doi:10.1128/jvi.00983-14 · Cited by 132
Wang, Q. A., Miller, D. J., Bowman, E., Nagarkar, D. R., Schneider, D., Zhao, Y., Linn, M. J., Goldsmith, A. M., Bentley, J. K., Sajjan, U. S., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002070 · Cited by 125
Mitchell, H. D., Eisfeld, A. J., Sims, A. M., McDermott, J., Matzke, M. M., Webb‐Robertson, B., Tilton, S. C., Tchitchek, N., Josset, L., Li, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069374 · Cited by 117
Self-citationHamelin, M., Prince, G. A., Gomez-Lahoz, A. M., Kinkead, R., & Boivin, G. (2006) · The Journal of Infectious Diseases · doi:10.1086/504262 · Cited by 105
Seo, S., Kwon, H.-J., Song, J.-H., Byun, Y.-H., Seong, B. L., Kawai, T., Akira, S., & Kweon, M. (2010) · Journal of Virology · doi:10.1128/jvi.01675-10 · Cited by 104
Khanolkar, A., Hartwig, S. M., Haag, B. A., Meyerholz, D. K., Harty, J. T., & Varga, S. M. (2009) · Journal of Virology · doi:10.1128/jvi.01857-08 · Cited by 69
A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant
Agnihothram, S., Yount, B. L., Donaldson, E., Huynh, J., Menachery, V. D., Gralinski, L. E., Graham, R. L., Becker, M. M., Tomar, S., Scobey, T., et al. (2014) · mBio · doi:10.1128/mbio.00047-14 · Cited by 56
Self-citationDetection of Severe Acute Respiratory Syndrome-Associated Coronavirus in Pneumocytes of the Lung
Chow, K., Hsiao, C.-H., Lin, T., Chen, C., & Chiou, S.-H. (2004) · American Journal of Clinical Pathology · doi:10.1309/c0ed-u0ra-qbtx-bhce · Cited by 54
Pérez-Girón, J. V., Belicha‐Villanueva, A., Hassan, E., Gómez‐Medina, S., Cruz, J. L. G., Lüdtke, A., Ruibal, P., Albrecht, R. A., García‐Sastre, A., & Muñoz‐Fontela, C. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400222 · Cited by 49
Menasria, R., Boivin, N., Lebel, M., Piret, J., Gosselin, J., & Boivin, G. (2013) · Journal of Virology · doi:10.1128/jvi.00591-13 · Cited by 42
Palmer, L. A., May, W. J., deRonde, K. A., Brown-Steinke, K., Gaston, B. M., & Lewis, S. J. (2012) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2012.11.010 · Cited by 41
Differential Ability of Surface and Endosomal TLRs To Induce CD8 T Cell Responses In Vivo
Mandraju, R., Murray, S. E., Forman, J., & Pasare, C. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302244 · Cited by 41
Leung, C. Y. H., Nicholls, J. M., Ho, C.-K., Sia, S. F., Mok, C. K. P., Valkenburg, S. A., Cheung, P. P., Hui, K. P. Y., Chan, R. W. Y., Guan, Y., et al. (2014) · Journal of General Virology · doi:10.1099/vir.0.066258-0 · Cited by 40
Loss of TLR4 Does Not Prevent Influenza A–induced Mortality
Morales‐Nebreda, L., Mutlu, G. M., Budinger, G. R. S., & Radigan, K. A. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201401-0193le · Cited by 8
Cited by
Channappanavar, R., & Perlman, S. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0629-x · Cited by 2,524
Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
Tang, Y., Liu, J., Zhang, D., Xu, Z., Ji, J., & Wen, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01708 · Cited by 1,094
Activation and evasion of type I interferon responses by SARS-CoV-2
Lei, X., Dong, X., Ma, R., Wang, W., Xiao, X., Tian, Z., Wang, C., Wang, Y., Li, L., Ren, L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17665-9 · Cited by 980
Type I and Type III Interferons – Induction, Signaling, Evasion, and Application to Combat COVID-19
Park, A., & Iwasaki, A. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.05.008 · Cited by 909
A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice
Leist, S. R., Dinnon, K. H., Schäfer, A., Tse, L. V., Okuda, K., Hou, Y. J., West, A., Edwards, C. E., Sanders, W., Fritch, E. J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.050 · Cited by 613
Self-citation
Metadata
- Authors
- Totura, A. L., Whitmore, A., Agnihothram, S., Schäfer, A., Katze, M. G., Heise, M. T., & Baric, R. S.
- Venue
- mBio
- Publisher
- American Society for Microbiology
- Published
- 2015-07
- Volume
- 6
- Issue
- 3
- Pages
- e00638-15
- ISSN
- 2150-7511 (ISSN-L)
- 2161-2129
- OpenAlex
- W2164013535
- Cited by
- 455
- References
- 60
- FWCI
- 3.57
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.